Genome signatures of colon carcinoma cell lines

被引:59
作者
Kleivi, K
Teixeira, MR
Eknæs, M
Diep, CB
Jakobsen, KS
Hamelin, R
Lothe, RA
机构
[1] Norwegian Radium Hosp, Inst Canc Res, Dept Genet, N-0310 Oslo, Norway
[2] Portuguese Oncol Inst, Dept Genet, Oporto, Portugal
[3] Univ Oslo, Inst Biol, Div Cell & Mol Biol, N-0316 Oslo, Norway
[4] INSERM, Paris, France
关键词
D O I
10.1016/j.cancergencyto.2004.03.014
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In cancer biology, cell lines are often used instead of primary tumors because of their widespread availability and close reflection of the in vivo state. Cancer is a genetic disease, commonly caused by small- and large-scale DNA rearrangements. Therefore, it is essential to know the genomic profiles of tumor cell lines to enable their correct and efficient use as experimental tools. Here, we present a comprehensive study of the genomic profiles of 20 colon cancer cell lines combining conventional karyotyping (G-banding), comparative genomic hybridization (CGH), and multicolor fluorescence in situ hybridization (M-FISH). Major differences between the microsatellite instability (MSI) and chromosome instability (CIN) cell lines are shown; the CIN cell lines exhibited complex karyotypes involving many chromosomes (mean: 8.5 copy number changes), whereas the MSI cell lines showed considerably fewer aberrations (mean: 2.6). The 3 techniques complement each other to provide a detailed picture of the numerical and structural chromosomal changes that characterize cancer cells. Therefore, 7 of the cell lines (Colo320, EB, Fri, IS2, IS3, SW480, and V9P) are here completely karyotyped for the first time and, among these, 5 have not previously been cytogenetically described. By hierarchical cluster analysis, we show that the cell lines are representative models for primary carcinomas at the genome level. We also present the genomic profiles of an experimental model for tumor progression, including 3 cell lines (IS 1, IS2, and IS3) established from a primary carcinoma, its corresponding liver- and peritoneal metastasis from the same patient. To address the question of clonality, we compared the genome of 3 common cell lines grown in 2 laboratories. Finally, we compared all our results with previously published CGH data and karyotypes of colorectal cell lines. In conclusion, the large variation in genetic complexity of the cell lines highlights the importance of a comprehensive reference of genomic profiles for investigators engaged in functional studies using these research tools. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:119 / 131
页数:13
相关论文
共 67 条
[1]   CLUES TO THE PATHOGENESIS OF FAMILIAL COLORECTAL-CANCER [J].
AALTONEN, LA ;
PELTOMAKI, P ;
LEACH, FS ;
SISTONEN, P ;
PYLKKANEN, L ;
MECKLIN, JP ;
JARVINEN, H ;
POWELL, SM ;
JEN, J ;
HAMILTON, SR ;
PETERSEN, GM ;
KINZLER, KW ;
VOGELSTEIN, B ;
DELACHAPELLE, A .
SCIENCE, 1993, 260 (5109) :812-816
[2]   Spectral karyotyping suggests additional subsets of colorectal cancers characterized by pattern of chromosome rearrangement [J].
Abdel-Rahman, WM ;
Katsura, K ;
Rens, W ;
Gorman, PA ;
Sheer, D ;
Bicknell, D ;
Bodmer, WF ;
Arends, MJ ;
Wyllie, AH ;
Edwards, PAW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (05) :2538-2543
[3]  
Arribas R, 1999, CLIN CANCER RES, V5, P3454
[4]   KARYOTYPIC CHARACTERIZATION OF COLORECTAL ADENOCARCINOMAS [J].
BARDI, G ;
SUKHIKH, T ;
PANDIS, N ;
FENGER, C ;
KRONBORG, O ;
HEIM, S .
GENES CHROMOSOMES & CANCER, 1995, 12 (02) :97-109
[5]   Aberrant expression of G1-phase cell cycle regulators in flat and exophytic adenomas of the human colon [J].
Bartkova, J ;
Thullberg, M ;
Slezak, P ;
Jaramillo, E ;
Rubio, C ;
Thomassen, LH ;
Bartek, J .
GASTROENTEROLOGY, 2001, 120 (07) :1680-1688
[6]   Relation between cytogenetic characteristics of two human colonic adenocarcinoma cell lines and their ability to grow locally or metastasize or both: An experimental study in the nude mouse [J].
Bertrand, V ;
Couturier-Turpin, MH ;
Louvel, A ;
Panis, Y ;
Couturier, D .
CANCER GENETICS AND CYTOGENETICS, 1999, 113 (01) :36-44
[7]  
BRATTAIN MG, 1981, CANCER RES, V41, P1751
[8]  
Cajot JF, 1997, CANCER RES, V57, P2593
[9]  
CASPERSSON T, 1970, CHROMOSOMA, V30, P215
[10]  
CHEN TR, 1994, ANTICANCER RES, V14, P109